6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide,
GSK-AHAB,
GW856553,
losmapimod,
Losmapimod,
585543-15-3,
GSK-AHAB,
GW856553,
GW856553X,
Losmapimod (GW856553X),
UNII-F2DQF16BXE,
GW-856553,
F2DQF16BXE,
6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide,
Losmapimod [USAN:INN],
GSKAHAB,
GW 856553X,
SB 856553,
Losmapimod (USAN/INN),
GTPL7835,
SCHEMBL1070401,
CHEMBL1088752,
EX-A486,
CHEBI:131167,
KKYABQBFGDZVNQ-UHFFFAOYSA-N,
HMS3653G19,
losmapimod pound>>GW-856553,
AOB87105,
BCP09909,
2523AH,
BDBM50418610,
MFCD16619322,
s7215,
ZINC35793138,
AKOS015994587,
CS-3235,
DB12270,
GE-0056,
SB16761,
NCGC00386332-03,
6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methyl-phenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide,
AK547876,
AN-27884,
BC600588,
GS856553,
HY-10402,
GW 856553,
B4620,
FT-0700337,
SW219307-1,
D09639,
543C153,
6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-neopentylnicotinamide,
6-(5-cyclopropylcarbamoyl-3-fluoro-2-methyl-phenyl)-N-(2,2-dimethylpropyl)-nicotinamide,
3-pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-,
GSK-AHAB|||GW-856553X|||6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide,
D0C8DD,
C22H26FN3O2,
CID11552706,
A12526,
C543534,
GSK-AHAB;GW856553X;SB856553;GW 856553X;SB 856553;GW-856553X;SB-856553,
6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide,